About
Innogenetics NV develops and markets diagnostic products for therapy management and patient health. Its diagnostics business focuses on developing products for infectious diseases, genetic testing, tissue typing, neurodegeneration, and oncology. Its products in the area of infectious diseases include screening and confirmation tests for HIV, HCV, HTLV, and syphilis; genotyping tests for hepatitis B virus (HBV), human papillomavirus, and mycobacterium sp; and drug-resistance tests for TB and HBV. Innogenetics also offers genetic testing products comprising detection tests for cystic fibrosis, as well as MBL2 and APO E genetic variants associated with genetic risks; tissue typing tests to determine the type of HLA; and neurodegeneration products, which include tests for Alzheimer's disease. In the Oncology area, the company distributes AdnaGen AG’s diagnostics products for breast and colon cancer. Its therapeutics business engages in the development of therapeutic vaccines for the treatm
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 46 investors are based in Gent, Oost-Vlaanderen, Belgium.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Gent, Belgium
Contact Information
Find more investors like Innogenetics
Search Investors